{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:40Z","timestamp":1793073700064,"version":"4.5.0"},"reference-count":45,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can share similar features, posing diagnostic challenges. In this study, we identified sets of conventional MRI lesion distribution criteria proposed for disease differentiation and investigated their clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched five electronic databases for English-written and peer-reviewed diagnostic accuracy studies that included brain MRI at least. Hierarchical and univariate random-effects logistic regression models were employed for diagnostic accuracy meta-analysis. Heterogeneity was explored with subgroup analyses. Certainty of evidence was assessed using the GRADEpro tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three sets of criteria (\u2018Matthews\u2019, \u2018Cacciaguerra\u2019, \u2018MS lesion checklist\u2019) were investigated in 11 studies (2008 patients; MS, n=1037; NMOSD, n=842; MOGAD, n=129), with low applicability concerns. Overall pooled sensitivity and specificity of the Matthews brain MRI criteria (MS vs seropositive-NMOSD differentiation) were 0.92 (0.86 to 0.96) and 0.85 (0.79 to 0.90), respectively, with higher diagnostic values in non-Caucasian populations and during follow-up. Pooled sensitivity and specificity of the Cacciaguerra brain-spinal cord criteria (seropositive-NMOSD vs MS differentiation) were 0.96 (0.76 to 0.99) and 0.83 (0.71 to 0.90), respectively. The MS lesion checklist (MS vs NMOSD\/MOGAD differentiation) had lower diagnostic accuracy measures (sensitivity, specificity: 0.74, 0.79, respectively). The Matthews criteria provided the strongest moderate certainty evidence and also showed high pooled diagnostic accuracy for MS versus seronegative-NMOSD (sensitivity: 0.93 (0.84 to 0.97)); specificity: 0.90 (0.80 to 0.95)) and for MS versus MOGAD differentiation (sensitivity: 0.86 (0.81 to 0.90); specificity: 0.87 (0.76 to 0.93)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lesion distribution criteria can accurately discriminate between MS, NMOSD and MOGAD. Further optimised validation studies, and revisions or extensions may support sustained implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023472178.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336694","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:55:18Z","timestamp":1756713318000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-7082","authenticated-orcid":false,"given":"Vasilis-Spyridon","family":"Tseriotis","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Public Health, University College London Research Department of Epidemiology and Public Health, London, England, UK"},{"name":"Laboratory of Clinical Pharmacology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Makedonia Thraki, Greece"},{"name":"Department of Neurology, Agios Pavlos General Hospital of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-5510","authenticated-orcid":false,"given":"Georgina","family":"Arrambide","sequence":"additional","affiliation":[{"name":"Neurology-Neuroimmunology Department, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-5726","authenticated-orcid":false,"given":"Edgar","family":"Carnero Contentti","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Department of Neurosciences, Hospital Alem\u00e1n, Buenos Aires, Argentina"},{"name":"CENRos, Neuroimmunology Clinic, INECO Neurociencias Oro\u00f1o, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Tur","sequence":"additional","affiliation":[{"name":"Neurology-Neuroimmunology Department, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike P","family":"Wattjes","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9803-7914","authenticated-orcid":false,"given":"Rosa","family":"Cortese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos-Dimitrios","family":"Mitsikostas","sequence":"additional","affiliation":[{"name":"First Department of Neurology, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4278-3301","authenticated-orcid":false,"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Center, Second Department of Neurology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Adamou","sequence":"additional","affiliation":[{"name":"Institute for Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Dimitris","family":"Chlorogiannis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Beltsios","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-5222","authenticated-orcid":false,"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet Glostrup, Copenhagen, Denmark"},{"name":"Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital \u2013 Rigshospitalet Glostrup, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Clement","family":"Truelsen","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[{"name":"Experimental Neurophysiology Unit, Institute of Experimental Neurology (INSPE), Scientific Institute IRCCS San Raffaele, Milan, Italy"},{"name":"Vita-Salute San Raffaele University, Milan, Italy"},{"name":"Department of Neurorehabilitation Sciences, Casa di Cura Igea, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[{"name":"Neurology-Neuroimmunology Department, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"2025121202251627000_97.1.59.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00148-5"},{"key":"2025121202251627000_97.1.59.2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nic.2024.03.001","article-title":"Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease","volume":"34","author":"Filippi","year":"2024","journal-title":"Neuroimaging Clin N Am"},{"key":"2025121202251627000_97.1.59.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11910-z"},{"key":"2025121202251627000_97.1.59.4","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251627000_97.1.59.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025121202251627000_97.1.59.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.01.008"},{"key":"2025121202251627000_97.1.59.7","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0345-y"},{"key":"2025121202251627000_97.1.59.8","doi-asserted-by":"crossref","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"2025121202251627000_97.1.59.9","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2025121202251627000_97.1.59.10","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2015.16.6.1188"},{"key":"2025121202251627000_97.1.59.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-022-01788-2","article-title":"Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data","volume":"22","author":"Plana","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"2025121202251627000_97.1.59.12","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215592269"},{"key":"2025121202251627000_97.1.59.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0724-x","article-title":"Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA","volume":"19","author":"Freeman","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"2025121202251627000_97.1.59.14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jrsm.1439","article-title":"Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta-analysis of diagnostic test accuracy data","volume":"12","author":"Patel","year":"2021","journal-title":"Res Synth Methods"},{"key":"2025121202251627000_97.1.59.15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/cclm-2022-1256","article-title":"Tutorial: statistical methods for the meta-analysis of diagnostic test accuracy studies","volume":"61","author":"Schlattmann","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2025121202251627000_97.1.59.16","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6115"},{"key":"2025121202251627000_97.1.59.17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2020.11.011","article-title":"New measures improved the reporting of heterogeneity in diagnostic test accuracy reviews: a metaepidemiological study","volume":"131","author":"Plana","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2025121202251627000_97.1.59.18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.msard.2018.08.008","article-title":"Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis","volume":"25","author":"Bensi","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"2025121202251627000_97.1.59.19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25411"},{"key":"2025121202251627000_97.1.59.20","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/acn3.50913","article-title":"Brain lesion distribution criteria distinguish demyelinating diseases in China","volume":"6","author":"Cai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2025121202251627000_97.1.59.21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1352458520939008","article-title":"Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder","volume":"27","author":"Cai","year":"2021","journal-title":"Mult Scler"},{"key":"2025121202251627000_97.1.59.22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458519849517","article-title":"Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients","volume":"26","author":"Carnero Contentti","year":"2020","journal-title":"Mult Scler"},{"key":"2025121202251627000_97.1.59.23","doi-asserted-by":"crossref","first-page":"103778","DOI":"10.1016\/j.msard.2022.103778","article-title":"Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios","volume":"61","author":"Carnero Contentti","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2025121202251627000_97.1.59.24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314005"},{"key":"2025121202251627000_97.1.59.25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2022.04.035","article-title":"Development and validation of a simple and practical method for differentiating MS from other neuroinflammatory disorders based on lesion distribution on brain MRI","volume":"101","author":"Patel","year":"2022","journal-title":"J Clin Neurosci"},{"key":"2025121202251627000_97.1.59.26","doi-asserted-by":"crossref","first-page":"110063","DOI":"10.1016\/j.ejrad.2021.110063","article-title":"Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset: A retrospective analysis in a single-center cohort","volume":"146","author":"Zrzavy","year":"2022","journal-title":"Eur J Radiol"},{"key":"2025121202251627000_97.1.59.27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/1352458518761186","article-title":"Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis","volume":"25","author":"Hyun","year":"2019","journal-title":"Mult Scler"},{"key":"2025121202251627000_97.1.59.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2025121202251627000_97.1.59.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"2025121202251627000_97.1.59.30","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20703"},{"key":"2025121202251627000_97.1.59.31","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120 (Pt 11)","author":"Barkhof","year":"1997","journal-title":"Brain (Bacau)"},{"key":"2025121202251627000_97.1.59.32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025121202251627000_97.1.59.33","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251627000_97.1.59.34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025121202251627000_97.1.59.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2025121202251627000_97.1.59.36","doi-asserted-by":"crossref","first-page":"543047","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"key":"2025121202251627000_97.1.59.37","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1177\/1352458519888609","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","volume":"26","author":"Kim","year":"2020","journal-title":"Mult Scler"},{"key":"2025121202251627000_97.1.59.38","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00431-8"},{"key":"2025121202251627000_97.1.59.39","doi-asserted-by":"publisher","DOI":"10.1177\/1756285613484079"},{"key":"2025121202251627000_97.1.59.40","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233099","article-title":"Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort","volume":"313","author":"Chien","year":"2024","journal-title":"Radiology"},{"key":"2025121202251627000_97.1.59.41","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1177\/13524585231187120","article-title":"Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting","volume":"29","author":"Carnero Contentti","year":"2023","journal-title":"Mult Scler"},{"key":"2025121202251627000_97.1.59.42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37833","article-title":"Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder","volume":"4","author":"Camera","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025121202251627000_97.1.59.43","first-page":"e1097","article-title":"Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders","volume":"97","author":"Sechi","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251627000_97.1.59.44","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209303","article-title":"Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease","volume":"102","author":"Cacciaguerra","year":"2024","journal-title":"Neurology (ECronicon)"},{"key":"2025121202251627000_97.1.59.45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1474-4422(24)00256-4","article-title":"Differential diagnosis of suspected multiple sclerosis: global health considerations","volume":"23","author":"Correale","year":"2024","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:26:03Z","timestamp":1765535163000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/jnnp-2025-336694"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336694","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}